230
Views
33
CrossRef citations to date
0
Altmetric
Review Article

Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation

, &
Pages 168-177 | Received 14 Aug 2012, Accepted 07 Dec 2012, Published online: 17 Jan 2013

References

  • Allard-Vannier E, Cohen-Jonathan S, Gautier J, et al. (2012). Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo. Eur J Pharm Biopharm 81:498–505
  • Bhattacharjee S, De Haan L, Evers N, et al. (2010). Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol 7:25
  • Blander JM, Medzhitov R. (2006). On regulation of phagosome maturation and antigen presentation. Nat Immunol 7:1029–35
  • Bonner J, Silva R, Taylor A, et al. (in press). Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials. Environ Health Perspect
  • Brown DM, Kinloch IA, Bangert U, et al. (2007). An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 45:1743–56
  • Brown JM, Wilson TM, Metcalfe DD. (2008). The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 38:4–18
  • Carlson C, Hussain SM, Schrand AM, et al. (2008). Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608–19
  • Carroll MV, Sim RB. (2011). Complement in health and disease. Adv Drug Deliv Rev 63:965–75
  • Cesta MF, Ryman-Rasmussen JP, Wallace DG, et al. (2010). Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. Am J Resp Cell Mol Biol 43:142–51
  • Chen E, Garnica M, Wang YC, et al. (2012). A mixture of anatase and rutile TiO2 nanoparticles induces histamine secretion in mast cells. Part Fibre Toxicol 9:2
  • Chiossone L, Chaix J, Fuseri N, et al. (2009). Maturation of mouse NK cells is a 4-stage developmental program. Blood 113:5488–96
  • Christian V, Heidi F, Rachel C, et al. (2010). Analysis of the toxicity of gold nanoparticles on the immune system: effect on dendritic cell functions. J Nanopart Res 12:55–60
  • Christopher C. (2010). The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 34:J234–46
  • Cruz LJ, Tacken PJ, Pots JM, et al. (2012). Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN. Biomaterials 33:4229–39
  • Cui Y, Liu H, Ze Y, et al. (2012). Gene expression in liver injury caused by long-term exposure to titanium dioxide nanoparticles in mice. Toxicol Sci 128:171–85
  • Dobrovolskaia MA, Aggarwal P, Hall JB, Mcneil SE. (2008). Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–95
  • Duan Y, Liu J, Ma L, et al. (2010). Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials 31:894–99
  • Dutta D, Sundaram SK, Teeguarden JG, et al. (2007). Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 100:303–15
  • George S, Lin S, Ji Z, et al. (2012). Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryos. ACS Nano 6:3745–59
  • Gilfillan AM, Tkaczyk C. (2006). Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6:218–30
  • Gougeon ML, Melki MT, Saidi H. (2012). HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ 19:96–106
  • Grimm J, Scheinberg DA. (2011). Will nanotechnology influence targeted cancer therapy? Semin Radiat Oncol 21:80–7
  • Haase A, Arlinghaus HF, Tentschert J, et al. (2011). Application of laser postionization secondary neutral mass spectrometry/time-of-flight secondary ion mass spectrometry in nanotoxicology: visualization of nanosilver in human macrophages and cellular responses. ACS Nano 5:3059–68
  • Hamad I, Christy HA, Rutt KJ, et al. (2008). Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol Immunol 45:3797--803
  • Hayakawa H, Hayakawa M, Kume A, Tominaga SI. (2007). Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282:26369–80
  • Heng B, Zhao X, Tan E, et al. (2011). Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch Toxicol 85:1517–28
  • Hirai T, Yoshikawa T, Nabeshi H, et al. (2012). Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection. Part Fibre Toxicol 9:3
  • Hussain S, Vanoirbeek, JAJ, Luyts K, et al. (2011). Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 37:299–309
  • Kapralov AA, Feng WH, Amoscato AA, et al. (2012). Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 6:4147–56
  • Kasturi SP, Skountzou I, Albrecht RA, et al. (2011). Programming the magnitude and persistence of antibody responses with innate immunity. Nature, 470:543–7
  • Katwa P, Wang X, Urankar RN, et al. (2012). A carbon nanotube toxicity paradigm driven by mast cells and the IL-33/ST2 axis. Small 8:2904–12
  • Kim JA, Aberg C, Salvati A, Dawson KA. (2011a). Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol 7:62–8
  • Kim JS, Adamcakova-Dodd A, O’shaughnessy P, et al. (2011b). Effects of copper nanoparticle exposure on host defense in a murine pulmonary infection model. Part Fibre Toxicol 8:29
  • Kunzmann A, Andersson B, Vogt C, et al. (2011). Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol 253:81–93
  • Liu Z, Robinson JT, Tabakman SM, et al. (2011). Carbon materials for drug delivery & cancer therapy. Mater Today 14:316–23
  • Lunov O, Syrovets T, Loos C, et al. (2011). Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages. ACS Nano 5:9648–57
  • Manolova V, Flace A, Bauer M, et al. (2008). Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 38:1404–13
  • Mayer A, Vadon M, Rinner B, et al. (2009). The role of nanoparticle size in hemocompatibility. Toxicology 258:139–47
  • Migdal C, Rahal R, Rubod A, et al. (2010). Internalisation of hybrid titanium dioxide/para-amino benzoic acid nanoparticles in human dendritic cells did not induce toxicity and changes in their functions. Toxicol Lett 199:34–42
  • Miller A. (2011). Role of IL-33 in inflammation and disease. J Inflam 8:22
  • Misra R, Acharya S, Sahoo SK. (2010). Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today 15:842–50
  • Mitchell LA, Lauer FT, Burchiel SW, Mcdonald JD. (2009). Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nano 4:451–56
  • Moon EY, Yi GH, Kang JS, et al. (2011). An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles. J Immunotoxicol 8:56–67
  • Murphy F, Schinwald A, Poland C, Donaldson K. (2012). The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part Fibre Toxicol 9:8
  • Nel AE, Madler L, Velegol D, et al. (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–557
  • Norton SK, Dellinger A, Zhou Z, et al. (2010). A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release. Clin Transl Sci 3:158--69
  • Park EJ, Park K. (2009). Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett 184:18–25
  • Park EJ, Kim H, Kim Y, Park K. (2010). Intratracheal instillation of platinum nanoparticles may induce inflammatory responses in mice. Arch Pharm Res 33:727–35
  • Park EJ, Yoon J, Choi K, et al. (2009). Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation. Toxicology 260:37–46
  • Ruge CA, Kirch J, Cañadas O, et al. (2011). Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine 7:690–93
  • Ryan JJ, Bateman HR, Stover A, et al. (2007). Fullerene nanomaterials inhibit the allergic response. J Immunol 179:665–72
  • Rybak-Smith MJ, Sim RB. (2011). Complement activation by carbon nanotubes. Adv Drug Deliv Rev 63:1031–41
  • Ryman-Rasmussen JP, Tewksbury EW, Moss OR, et al. (2009). Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am J Respir Cell Mol Biol 40:349–58
  • Salvador-Morales C, Flahaut E, Sim E, et al. (2006). Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 43:193–201
  • Sang X, Zheng L, Sun Q, et al. (2012). The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles. J Biomed Mater Res A 100A:894–902
  • Sayes CM, Reed KL, Warheit DB. (2007). Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163--80
  • Schanen BC, Karakoti AS, Seal S, et al. (2009). Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano 3:2523–32
  • Shannahan JH, Kodavanti UP, Brown JM. (2012). Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal Toxicol 24:320–39
  • Takenaka S, Moller W, Semmler-Behnke M, et al. (2012). Efficient internalization and intracellular translocation of inhaled gold nanoparticles in rat alveolar macrophages. Nanomedicine (Lond) 7:855–65
  • Tsai CY, Lu SL, Hu CW, et al. (2012). Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J Immunol 188:68–76
  • Walkey CD, Chan WCW. (2012). Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41:2780–99
  • Wang X, Katwa P, Podila R, et al. (2011). Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice. Part Fibre Toxicol 8:24
  • Wingard CJ, Walters DM, Cathey BL, et al. (2011). Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology 5:531–45
  • Winter M, Beer HD, Hornung V, et al. (2011). Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology 5:326--40
  • Xiao K, Li Y, Luo J, et al. (2011). The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 32:3435–46
  • Yanagisawa R, Takano H, Inoue KI, et al. (2009). Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice. Exp Biol Med 234:314–22
  • Yang EJ, Kim S, Kim JS, Choi IH. (2012). Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles. Biomaterials 33:6858–67
  • Yazdi AS, Guarda G, Riteau N, et al. (2010). Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci 107:19449–54
  • Yeramilli VA, Knight KL. (2011). Somatically diversified and proliferating transitional B cells: implications for peripheral B cell homeostasis. J Immunol 186:6437–44
  • Zhang Y, Bai Y, Yan B. (2010). Functionalized carbon nanotubes for potential medicinal applications. Drug Discov Today 15:428–35
  • Zhang LW, Baumer W, Monteiro-Riviere NA. (2011). Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine (Lond) 6:777–91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.